Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 207 publications
An Exosomal Signature for Preoperative Detection of Occult Liver Metastasis in Pancreatic Cancer.
Journal: JAMA surgery
Published: September 02, 2026
A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM), and paricalcitol as neoadjuvant therapy in pancreatic cancer.
Journal: The oncologist
Published: March 02, 2026
Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence.
Journal: NPJ precision oncology
Published: February 09, 2026
Pancreatic cyst epidemiology defined by endoscopic ultrasound: A single-center longitudinal study.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: January 08, 2026
Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer.
Journal: Redox biology
Published: October 09, 2025
A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer.
Journal: Cancer
Published: September 10, 2025
Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced KRAS-Mutated Metastatic Pancreatic Cancer.
Journal: Journal of immunotherapy and precision oncology
Published: August 11, 2025
Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors.
Journal: Cancer research communications
Published: March 04, 2025
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.
Journal: Nature cancer
Published: January 01, 2025
Last Updated: 09/26/2026